IPF

Questions discussed in this category

Do you ever consider close clinical monitoring over antifibrotic therapy in patients ascribed an MDD diagnosis of IPF who have normal lung function and are asymptomatic?

2 Answers available

Is there an age at which you consider not starting antifibrotic therapy in a patient with IPF?

1 Answer available

Does your approach to the management of a patient with an acute exacerbation of CPFE where the ILD is attributed to IPF differ from the management of a patient with an exacerbation of IPF alone?

1 Answer available

How do you counsel patients regarding prognosis following a diagnosis of IPF?

1 Answer available

Papers discussed in this category

American journal of respiratory and critical care medicine, 2011-02-15

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

Chest, 2011-07

Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium.

The Lancet. Respiratory medicine, 2017-12

Palliative care in interstitial lung disease: living well.

J Heart Lung Transplant, 2021 Nov

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

ERJ Open Res, 2019 Jul 08

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry.

BMC Pulm Med, 2018 Jan 17

Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey.

The Lancet. Respiratory medicine, 2021 Sep 07

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.

American journal of respiratory and critical care medicine, 2020 May 01

Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.

Chest, 2018 Jun 30

Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.

The European respiratory journal, 2010 Jul 01

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.

Transplantation, 2024 May 23

Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes.

American journal of respiratory and critical care medicine, 2019 Jul 15

Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis.

PloS one, 2022 Feb 03

Tolerability of nintedanib in the elderly with idiopathic pulmonary fibrosis: A single-center retrospective study.

Respiration; international review of thoracic diseases, 2022 Nov 10

Observational, Multicenter Study on the Efficacy, Tolerability, and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis Older than 80 Years.

Lancet (London, England), 2011-05-21

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

The New England journal of medicine, 2018 Aug 26

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

Respiratory research, 2021 Apr 26

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities.

The New England journal of medicine, 2014 May 18

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

Respiratory investigation, 2020 Sep 03

Tolerability and safety of nintedanib in elderly patients with idiopathic pulmonary fibrosis.

Advances in therapy, 2023 Mar 16

A Narrative Review of Real-World Data on the Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine, 2011-10-01

Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study.

American journal of respiratory and critical care medicine, 2023 Jan 01

Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias.

IPF

Questions discussed in this category

Papers discussed in this category

Related Topics